Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia

por Karlsson, C, Dahl, H, Lundin, J, Rossmann, E, Brytting, M, Mellstedt, H, Linde, A, Österborg, A
Publicado 2011